1. Home
  2. Analysis
  3. Restoril
  4. Skin-plaque

Restoril and Skin plaque - a phase IV clinical study of FDA data

Summary:

Skin plaque is reported as a side effect among people who take Restoril (temazepam), especially for people who are female, 60+ old, also take Zantac, and have Metastatic neoplasm.

The phase IV clinical study analyzes which people have Skin plaque when taking Restoril. It is created by eHealthMe based on reports of 12,884 people who have side effects when taking Restoril from the FDA, and is updated regularly.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

What is Skin plaque?

Skin plaque (red, scaly patches to appear on the skin) is found to be associated with 525 drugs and 518 conditions by eHealthMe. Check the latest studies of Skin plaque.

On Jul, 06, 2026

12,884 people reported to have side effects when taking Restoril.
Among them, 17 people (0.13%) have Skin plaque.

Could Restoril cause Skin plaque?

Among these 17 people:

What is the gender of people who have Skin plaque when taking Restoril? *

  • female: 94.12 %
  • male: 5.88 %

What is the age of people who have Skin plaque when taking Restoril? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

What are other drugs people take besides Restoril? *

  1. Zantac: 15 people, 88.24%
  2. Bactrim: 10 people, 58.82%
  3. Keflex: 10 people, 58.82%
  4. Aciphex: 10 people, 58.82%
  5. Zometa: 10 people, 58.82%
  6. Dilaudid: 10 people, 58.82%
  7. Folic Acid: 10 people, 58.82%
  8. Aredia: 10 people, 58.82%
  9. Clarinex: 10 people, 58.82%
  10. Megace: 10 people, 58.82%

What are other side effects people have besides Skin plaque? *

  1. Pain: 17 people, 100.00%
  2. Joint Pain: 13 people, 76.47%
  3. Gait Disturbance: 12 people, 70.59%
  4. Depression: 11 people, 64.71%
  5. Actinic Keratosis (skin disease due to sun exposure): 10 people, 58.82%
  6. Nodal Osteoarthritis (a more painful form of osteoarthritis a affecting the end joints of fingers is called nodal osteoarthritis): 10 people, 58.82%
  7. Foot Fracture: 10 people, 58.82%
  8. Photodermatosis (skin disease that is caused by exposure to sunlight): 10 people, 58.82%
  9. Fungal Nail Infection: 10 people, 58.82%
  10. Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 58.82%

What are the existing conditions these people have? *

  1. Metastatic Neoplasm (spreadable cancer tumour): 4 people, 23.53%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.88%
  3. Pain: 1 person, 5.88%
  4. Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.88%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
  6. Headache (pain in head): 1 person, 5.88%
  7. Breast Cancer Metastatic: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Restoril and have Skin plaque?

- Check whether Skin plaque is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Restoril:

Skin plaque treatments and more:

How severe was Skin plaque and when was it recovered:

Expand to all the drugs that have ingredients of temazepam:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin plaque:

Browse all the conditions that are associated with Skin plaque:

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Restoril) and Restoril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.